Biomarker challenges for immune checkpoint inhibitors in urothelial carcinoma

被引：0
|
作者：
Tom Powles
Laura Morrison
机构：
[1] Queen Mary University of London St Bartholomew’s Hospital,Barts Cancer Institute Experimental Medicine Centre
来源：
Nature Reviews Urology | 2018年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Immune checkpoint inhibitors are associated with durable and well-tolerated responses in metastatic urothelial carcinoma. Predicting which patients respond to therapy has been challenging; however, progress has been made using programmed cell death 1 ligand 1 as a biomarker and a second generation of biomarkers, which are being assessed.
引用
收藏
页码：585 / 587
页数：2
相关论文
共 50 条
  • [1] Biomarker challenges for immune checkpoint inhibitors in urothelial carcinoma
    Powles, Tom
    Morrison, Laura
    [J]. NATURE REVIEWS UROLOGY, 2018, 15 (10) : 585 - 587
  • [2] Immune checkpoint inhibitors for urothelial carcinoma
    Albertsen, Peter
    [J]. BJU INTERNATIONAL, 2023, 132 (01) : 3 - 3
  • [3] Immune checkpoint inhibitors for urothelial carcinoma
    Kim, Hyung Suk
    Seo, Ho Kyung
    [J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2018, 59 (05) : 285 - 296
  • [4] Urothelial carcinoma in the era of immune checkpoint inhibitors
    Khalife, Nadine
    Chahine, Claude
    Kordahi, Manal
    Felefly, Tony
    Kourie, Hampig Raphael
    Saleh, Khalil
    [J]. IMMUNOTHERAPY, 2021, 13 (11) : 953 - 964
  • [5] The Evolution of Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Houssiau, Helene
    Seront, Emmanuel
    [J]. CANCERS, 2022, 14 (07)
  • [6] Urothelial carcinoma: the development of FGFR inhibitors in combination with immune checkpoint inhibitors
    Qin, Qian
    Patel, Vaibhav
    Galsky, Matthew D.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) : 503 - 512
  • [7] Immune checkpoint inhibitors as a real hope in advanced urothelial carcinoma
    Seront, Emmanuel
    Catala, Gaetan
    Dermine, Alexandre
    Lejeune, Sarah
    Rysselinck, Stephane
    [J]. FUTURE SCIENCE OA, 2018, 4 (10):
  • [8] Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Makrakis, Dimitrios
    Bakaloudi, Dimitra Rafailia
    Talukder, Rafee
    Lin, Genevieve Ihsiu
    Diamantopoulos, Leonidas N.
    Jindal, Tanya
    Vather-Wu, Naomi
    Zakharia, Yousef
    Tripathi, Nishita
    Agarwal, Neeraj
    Dawsey, Scott
    Gupta, Shilpa
    Lu, Eric
    Drakaki, Alexandra
    Liu, Sandy
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Fulgenzi, Claudia -Maria
    Cortellini, Alessio
    Pinato, David
    Barata, Pedro
    Grivas, Petros
    Khaki, Ali Raza
    Koshkin, Vadim S.
    [J]. CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 286 - 294
  • [9] Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Chen, Siteng
    Zhang, Ning
    Wang, Tao
    Zhang, Encheng
    Wang, Xiang
    Zheng, Junhua
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [10] Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker Selection
    Meeks, Joshua J.
    Black, Peter C.
    Galsky, Matthew
    Grivas, Petros
    Hahn, Noah M.
    Hussain, Syed A.
    Milowsky, Matthew I.
    Steinberg, Gary D.
    Svatek, Robert S.
    Rosenberg, Jonathan E.
    [J]. EUROPEAN UROLOGY, 2023, 84 (05) : 473 - 483
12345